Christian Lim
About Christian Lim
Christian Lim serves as the Senior Manager of Quality Systems at Erasca, Inc., where he has worked since 2022. He holds a Bachelor of Science in Biology from Virginia Commonwealth University and has extensive experience in quality assurance across several pharmaceutical companies.
Work at Erasca
Christian Lim currently serves as the Senior Manager of Quality Systems at Erasca, Inc., a position he has held since 2022. In this role, he oversees the quality systems within the organization, ensuring compliance with industry standards and regulations. Prior to this position, he worked as the Quality Systems Manager at Erasca from 2021 to 2022. His tenure at Erasca reflects a commitment to maintaining high-quality standards in the biopharmaceutical sector.
Education and Expertise
Christian Lim earned a Bachelor of Science degree in Biology from Virginia Commonwealth University, completing his studies from 2008 to 2013. This educational background provides him with a solid foundation in biological sciences, which supports his expertise in quality systems within the pharmaceutical industry.
Background
Before joining Erasca, Christian Lim gained extensive experience in quality assurance and systems management. He worked at Heron Therapeutics, Inc. as a Senior Quality Assurance Associate from 2019 to 2020. He also held the position of Quality Assurance Manager at Intercept Pharmaceuticals for five months in 2020. His career began at USAA as an Auto Adjuster in 2014, followed by a role at Catalent Pharma Solutions as a Manufacturing Quality Assurance Associate II from 2016 to 2019.
Career Progression
Christian Lim's career reflects a steady progression in the quality assurance field. After his initial role at USAA, he transitioned to Catalent Pharma Solutions, where he worked for three years in quality assurance. His subsequent positions at Intercept Pharmaceuticals and Heron Therapeutics further developed his skills in quality systems, leading to his current role at Erasca, where he continues to advance in the biopharmaceutical industry.